Firm News

Anapol Weiss Announces Promotion of Catelyn McDonough to Partner

Dec 10, 2024

Anapol Weiss is proud to announce the promotion of Catelyn McDonough to partner this month. A dedicated advocate for justice, Catelyn has been a driving force within the firm’s Pharmaceutical and Medical Device Mass Tort Litigation practice, where her passion for protecting victims—particularly women affected by harmful products—has distinguished her as a leader in her field. Catelyn is a key member of the firm’s Women’s Health Litigation Group, where her expertise and dedication have contributed to...

Anapol Weiss Files Three Depo-Provera Meningioma Lawsuits Against Pfizer

Dec 10, 2024

Anapol Weiss, a nationally recognized law firm dedicated to advocating for individuals harmed by defective products, recently announced the filing of three lawsuits on behalf of women who developed meningioma tumors following long-term use of Depo-Provera, a widely used injectable contraceptive. Each Depo lawsuit arises out of significant harm associated with the birth control injection. The lawsuits—filed in California on behalf of Kathleen Fazio, LaTosha White, and Rachel Valera Arceo—bring significant allegations against Pfizer, Inc. and...

$40 Million Settlement Secured for Vanguard Investors in Tax Liability Case

Dec 2, 2024

Anapol Weiss is proud to share the successful resolution of a significant legal battle, culminating in a $40 million settlement for Vanguard investors. The settlement addresses claims that Vanguard breached its fiduciary duties, resulting in substantial tax burdens for smaller investors who were forced to sell off assets. The case, filed in 2022, highlighted the impact of Vanguard's decision to lower fees by restructuring certain funds. This move inadvertently caused many investors in taxable accounts to...

Depo-Provera Lawsuits: Tracy Finken Magnotta Provides Update at HarrisMartin MDL CLE Conference on December 4

Nov 22, 2024

The status of the Depo-Provera meningioma lawsuits against Pfizer will be addressed by Anapol Weiss shareholder Tracy Finken Magnotta at the HarrisMartin MDL CLE Conference on Wednesday, December 4, in New York City. Magnotta and her team at Anapol Weiss filed one of the first lawsuits against Pfizer, alleging that the company failed to warn Depo-Provera users about the increased risk of developing meningioma tumors with prolonged use of the injectable contraceptive. Anapol Weiss is...

Personal Injury Boot Camp: Reviewing Insurance, Negotiating with the Adjuster & Demand Packages

Nov 15, 2024

On Wednesday November 20th, Anapol Weiss Partner Marni Berger will be presenting at a seminar for the National Bar Institute on best practices for trial lawyers to follow as they review the other side’s insurance information, negotiate with the insurance adjuster, and prepare demand packages. The seminar will begin with an overview of how counsel can perform insurance policy portfolio reviews. This starts with an understanding of the types of coverage available to the defendant and...

Supermarket News: Anapol Weiss Pursues Class-Action Lawsuit Against UNFI Over Alleged Supplier Discount Misuse

Nov 11, 2024

Supermarket News Senior Editor Bill Wilson recently reported on the class action lawsuit filed against United Natural Foods Inc. (UNFI) by Anapol Weiss, representing NYSM Organics LLC. Background of the Lawsuit and Allegations Against UNFI This lawsuit accuses UNFI of systematically and improperly applying prompt-payment discounts on supplier invoices, even when payments are delayed. Wilson’s article, which includes an interview with Anapol Weiss partner Patrick Huyett, provides insight into the legal complaint and the challenges facing smaller...

Anapol Weiss Files Class Action Against United Natural Foods, Inc. on Behalf of Natural Food Suppliers

Nov 8, 2024

UNFI’s Market Power and Influence Over Small Suppliers Anapol Weiss, in collaboration with Aaron Katz Law LLC and Wagstaff & Cartmell, LLP, has filed a class action lawsuit on behalf of NYSM Organics LLC and other similarly situated suppliers against United Natural Foods, Inc. (UNFI), one of the largest distributors of natural and organic foods in the United States. With a robust presence in the industry, UNFI operates over 50 distribution centers nationwide, servicing more...

Anapol Weiss Recognized Among Best Law Firms in U.S. and Metropolitan Tier 1 in Multiple Practice Areas by Best Lawyers® for 2025

Nov 8, 2024

Anapol Weiss is proud to announce its recognition in the 2025 edition of Best Lawyers® Best Law Firms. The firm has been ranked nationally for Mass Tort Litigation / Class Actions and has also earned Metropolitan Tier 1 rankings in multiple practice areas. This prestigious recognition underscores the firm’s commitment to excellence and its continued leadership in the legal community. Anapol Weiss was ranked for the following areas: Nationally: Mass Tort Litigation / Class Actions - Plaintiffs Metropolitan Tier...

Anapol Weiss Files Depo Lawsuit Against Pfizer Over Alleged Meningioma Tumors Link

Oct 28, 2024

San Francisco, CA – October 28, 2024 – The law firm of Anapol Weiss, known nationally for its leadership in mass tort litigation, today announced the filing of a personal injury lawsuit on behalf of Kathleen Fazio, a 56-year-old California woman, against pharmaceutical giant Pfizer, Inc. The lawsuit, filed in the United States District Court for the Central District of California, alleges that Fazio developed an intracranial meningioma (brain tumor) as a result of her use...

Anapol Weiss Attorneys Present on the Epidemiology of Depo-Provera and Other Progesterones, and the Incidence of Meningioma During HarrisMartin Webinar

Oct 24, 2024

On November 4, 2024, Anapol Weiss attorneys Tracy Finken Magnotta and Tom Anapol will be presenting as part of the HarrisMartin Webinar Series: Depo-Provera CI Litigation. Their presentation, titled "Epidemiology of Depo-Provera and Other Progesterones, The Incidence of Meningioma in the Population," will explore epidemiological data connecting the use of Depo-Provera and other progesterone-based treatments with an increased incidence of meningioma. The webinar will take place from 2:00 p.m. to 3:30 p.m. EST and offers CLE credit for attendees. This important presentation will...